Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

5-Oxoproline Enhances 4-Hydroxytamoxifen-induced Cytotoxicity by Increasing Oxidative Stress in MCF-7 Breast Cancer Cells

TAKANOBU NADAI, KATSUYA NARUMI, YUTO MUKAI, HINATA UEDA, AYAKO FURUGEN, YOSHITAKA SAITO and MASAKI KOBAYASHI
Anticancer Research March 2023, 43 (3) 1113-1120; DOI: https://doi.org/10.21873/anticanres.16256
TAKANOBU NADAI
1Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KATSUYA NARUMI
1Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: narumik{at}pharm.hokudai.ac.jp
YUTO MUKAI
1Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HINATA UEDA
1Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AYAKO FURUGEN
1Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHITAKA SAITO
2Department of Pharmacy, Hokkaido University Hospital, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAKI KOBAYASHI
1Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: masaki{at}pharm.hokudai.ac.jp
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Effect of glucose condition in the culture medium on HIF-1α protein expression level (A) and MCT1, MCT4, and c-MYC mRNA levels (B) in MCF-7 cells. (A) HIF-1α protein expression levels were analyzed by western blot analysis in MCF-7 cells. *p<0.05, compared to the high glucose condition using the unpaired Student’s t-test. Data are presented as the mean±standard error (SE) of three independent experiments. (B) Gene expression levels were analyzed by real-time PCR. *p<0.05 and **p<0.01, compared to the high glucose condition using the unpaired Student’s t-test. Data are presented as the mean±SE of three independent experiments.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Effect of 4-OHT combined with MCT inhibitors on MCF-7 cell viability under normal glucose conditions. Experiments were performed by exposing cells to 4-OHT combined with 5-OP or bindarit for 48 h. The sigmoid curve and IC50 values for cell growth inhibition by 4-OHT were determined using the MTT assay. *p<0.05 and **p<0.01, compared to the control using ANOVA followed by Dunnett’s test. Data are presented as the mean±standard error (SE) of three independent experiments. 4-OHT, 4-Hydroxytamoxifen; 5-OP, 5-oxoploline.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Confocal microscopy of cell morphology (A) and intracellular ATP levels (B) in MCF-7 cells during exposure to 4-OHT and 5-OP under normal glucose conditions. These experiments were performed by exposing cells to 4-OHT or 5-OP for 48 h. (A) Images of cell morphology observed by confocal microscopy. (B) Intracellular ATP was measured by the firefly luciferase luminescence method using an ATP assay kit. *p<0.05 and **p<0.01, compared to the control group; †p<0.01 compared to the 4-OHT 5 μM group; ‡p<0.01, compared to the 4-OHT 10 μM using ANOVA followed by Tukey-Kramer’s test. Data are presented as mean±standard error (SE) of three independent experiments. 4-OHT, 4-Hydroxytamoxifen; 5-OP, 5-oxoploline.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Effect of 4-OHT combined with 5-OP on SOD1 (A), SOD2 (B), and SOD3 (C) mRNA levels in MCF-7 cells under normal glucose conditions. SOD mRNA levels were measured by real-time PCR. *p<0.05 and **p<0.01, compared to the control group; †p<0.05 compared to the 5-OP group using ANOVA followed by Tukey-Kramer’s test. Data are presented as the mean±standard error (SE) of three independent experiments. 4-OHT, 4-Hydroxytamoxifen; 5-OP, 5-oxoploline.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Effect of 4-OHT combined with 5-OP on Nrf2 mRNA levels (A) and ROS (B) in MCF-7 cells under normal glucose conditions. (A) Nrf2 mRNA levels were measured by real-time PCR. **p<0.01, compared to the control group; †p<0.05, compared to the 5-OP group using ANOVA followed by Tukey-Kramer’s test. Data are presented as the mean±standard error (SE) of three independent experiments. (B) Total ROS levels were evaluated by DCFH in MCF-7 cells. *p<0.05 and **p<0.01, compared to the control group; †p<0.05, ††p<0.01 compared to the 5-OP group; ‡p<0.05 compared to the 4-OHT group using ANOVA followed by Tukey-Kramer’s test. Data are presented as the mean±SE of three independent experiments. 4-OHT, 4-Hydroxytamoxifen; 5-OP, 5-oxoploline.

Tables

  • Figures
  • Table I.
PreviousNext
Back to top

In this issue

Anticancer Research: 43 (3)
Anticancer Research
Vol. 43, Issue 3
March 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
5-Oxoproline Enhances 4-Hydroxytamoxifen-induced Cytotoxicity by Increasing Oxidative Stress in MCF-7 Breast Cancer Cells
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
12 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
5-Oxoproline Enhances 4-Hydroxytamoxifen-induced Cytotoxicity by Increasing Oxidative Stress in MCF-7 Breast Cancer Cells
TAKANOBU NADAI, KATSUYA NARUMI, YUTO MUKAI, HINATA UEDA, AYAKO FURUGEN, YOSHITAKA SAITO, MASAKI KOBAYASHI
Anticancer Research Mar 2023, 43 (3) 1113-1120; DOI: 10.21873/anticanres.16256

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
5-Oxoproline Enhances 4-Hydroxytamoxifen-induced Cytotoxicity by Increasing Oxidative Stress in MCF-7 Breast Cancer Cells
TAKANOBU NADAI, KATSUYA NARUMI, YUTO MUKAI, HINATA UEDA, AYAKO FURUGEN, YOSHITAKA SAITO, MASAKI KOBAYASHI
Anticancer Research Mar 2023, 43 (3) 1113-1120; DOI: 10.21873/anticanres.16256
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Study on the Synthesis and Structure-activity Relationship of 3-Styrylflavones Possessing Variously Hydroxylated D-ring Moiety
  • Real-time Capacity Reactance-based Innovative Technology for Detecting Malignant Cells: An Experimental Implementation in Head and Neck Tumors
  • Biological Features of Gastric Cancer After Neoadjuvant Chemotherapy
Show more Experimental Studies

Keywords

  • Tamoxifen
  • Monocarboxylate transporter
  • oxidative stress
  • breast cancer
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire